Erratum to: Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency
Crossref DOI link: https://doi.org/10.1007/s10875-017-0418-2
Published Online: 2017-07-17
Published Print: 2017-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wasserman, Richard L.
,
Melamed, Isaac R.
Stein, Mark R.
Jolles, Stephen
Norton, Miranda
Moy, James N.
Text and Data Mining valid from 2017-07-17
Article History
First Online: 17 July 2017